ARCHIVES

Risk Assessment Key In Long-Term Treatment

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002